N-acetylcysteine FLAP Inhibitor for Hemorrhagic Stroke
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Hemorrhagic stroke, characterized by bleeding within the brain, results in high mortality and long-term disability, with existing treatments lacking effective novel targets for intervention.
Innovation Solution
Administration of a therapeutically-effective amount of a 5-lipoxygenase activating protein (FLAP) inhibitor, such as N-acetylcysteine (NAC), to target nuclear ALOX5-derived reactive lipid species, thereby preventing cell death and enhancing functional recovery in central nervous system conditions, including hemorrhagic stroke.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If NAC is administered to treat hemorrhagic stroke, then neuronal degeneration is reduced and functional recovery is enhanced, but the mechanism of action involves neutralizing toxic lipid species which may have complex biochemical interactions
Solution Approach 1:
NAC acts as an intermediary substance that neutralizes toxic lipid species (reactive oxygen species) generated during hemorrhagic stroke. The compound donates electrons to these toxic species, converting them into harmless molecules, thereby mediating between the harmful byproducts of blood breakdown and the neuronal cells that would otherwise be damaged by oxidative stress
2Adaptability or versatility
If existing treatments are used for hemorrhagic stroke, then standard care is provided, but no effective novel targets for intervention are available
Solution Approach 1:
The invention changes the therapeutic parameter from conventional approaches (which target blood pressure or clot dissolution) to targeting the biochemical parameter of reactive oxygen species neutralization. By administering NAC, the treatment addresses the oxidative stress parameter that occurs during hemorrhagic stroke, providing a novel therapeutic mechanism that complements existing treatments
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
NAC effectively reduces neuronal degeneration and improves behavioral outcomes in animal models of hemorrhagic stroke by neutralizing toxic lipid species, offering a potential treatment for this condition.
Implementation Method 1
NAC effectively reduces neuronal degeneration and improves behavioral outcomes in animal models of hemorrhagic stroke by neutralizing toxic lipid species
Data Source
AI summary
The present disclosure describes methods of treating a central nervous system condition associated with oxidative stress using a 5-lipoxigenase activating protein (FLAP) inhibitor, for example, N-acetylcysteine or nordihydroguaiaretic acid. The present disclosure also describes methods of treating a central nervous system condition with N-acetylcysteine and a second therapeutic agent such as prostaglandin E2.